Dayforce, Scholar Rock, and More Stocks See Action From Activist Investors
Dayforce, Scholar Rock, and More Stocks See Action From Activist Investors Source link
Read more Dayforce, Scholar Rock, and More Stocks See Action From Activist InvestorsTag: Biopharmaceuticals
Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments
STUART, Fla., Feb. 1, 2024 /PRNewswire/ — Stuart Therapeutics, Inc. (“Stuart”), a clinical-stage biopharmaceutical company with candidate therapeutics in various phases of clinical development, today announced that it has…
Read more Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments
Intel, Tesla, Apple, Iovance, NetEase, Coherus BioSciences, and More Stock Market Movers
Updated Dec 27, 2023, 7:34 am EST / Original Dec 27, 2023, 4:26 am EST Stock futures traded slightly lower Wednesday after the S&P 500 finished higher Tuesday and…
Read more Intel, Tesla, Apple, Iovance, NetEase, Coherus BioSciences, and More Stock Market Movers
Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 Billion
Bristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash. Continue reading this article with a Barron’s subscription. View Options Source link
Read more Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 Billion
Bluebird Bio Stock Is in Free Fall
Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for the roughly 100,000 people in…
Read more Bluebird Bio Stock Is in Free Fall
Alphabet, Heico, Bluebird Bio, Plug Power, UBS, FedEx, and More Stock Market Movers
Dec 19, 2023, 4:31 am EST Stock futures traded flat Tuesday, a day after the S&P 500 finished up 0.5% and moved closer to its all-time. The broad…
Read more Alphabet, Heico, Bluebird Bio, Plug Power, UBS, FedEx, and More Stock Market Movers
Walmart, Nvidia, Novo Nordisk, Vista Outdoor, GM, and More Stock Market Movers
Stock futures pointed higher Friday as Wall Street returned for a shortened trading session following the Thanksgiving holiday. Retailers will be in focus on Black Friday, which marks…
Read more Walmart, Nvidia, Novo Nordisk, Vista Outdoor, GM, and More Stock Market Movers
Ardelyx wins long battle for FDA approval of kidney-disease treatment
Ardelyx Inc. ARDX, -0.58% on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease. The biopharma company…
Read more Ardelyx wins long battle for FDA approval of kidney-disease treatment
Lonza Warns on 2024 Profitability Hit From Lost Moderna Revenue
Updated Oct. 17, 2023 2:47 am ET Lonza Group warned that its profitability will take a hit next year from losing revenue from an agreement with Moderna and…
Read more Lonza Warns on 2024 Profitability Hit From Lost Moderna Revenue
Pfizer Earnings Beat. Guidance Disappoints.
Pfizer Stock Gains After Earnings Beat. Revenue and Outlook Aren’t So Good. Source link
Read more Pfizer Earnings Beat. Guidance Disappoints.
Alibaba, Dice, Arcellx, Avis, PayPal, and More Stock Market Movers
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/stock-market-movers-fb3791aa Updated June 20, 2023…
Read more Alibaba, Dice, Arcellx, Avis, PayPal, and More Stock Market Movers
AstraZeneca Says US Approved Lynparza as a Prostate Cancer Treatment
By Anthony O. Goriainoff AstraZeneca said Thursday that its and MSD’s Lynparza cancer treatment had been approved in the U.S. for the treatment of metastatic castration-resistant prostate cancer,…
Read more AstraZeneca Says US Approved Lynparza as a Prostate Cancer Treatment
Pfizer Agrees to Buy Seagen for $43 Billion
Pfizer Agrees to Buy Seagen for $43 Billion Source link
Read more Pfizer Agrees to Buy Seagen for $43 Billion
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales…
Read more Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
Novozymes and Chr. Hansen agree deal to merge
Danish biotechnology companies Novozymes AS NZYM.B, -10.74% and Chr. Hansen Holding AS CHR, +25.98% said Monday they have agreed to merge, creating a biological solutions provider with combined…
Read more Novozymes and Chr. Hansen agree deal to merge
WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon Therapeutics
WSJ News Exclusive Business U.S. biotechnology company was the last of three suitors standing in an auction for Horizon Source link
Read more WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon Therapeutics
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech…
Read more Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher” immune response in…
Read more Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
Pfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110 to $130 per dose once…
Read more Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose